Mark S. Cushman

Purdue University, West Lafayette, IN, United States 
Pharmaceutical Chemistry
"Mark Cushman"
Mean distance: (not calculated yet)


Sign in to add mentor
Neal Castagnoli grad student 1969-1973 UCSF
George H. Büchi post-doc 1973-1975 MIT


Sign in to add trainee
Mark L. Micklatcher grad student 2000 Purdue
Jinhua Chen grad student 2004 Purdue
Allison B. Edsall grad student 2004 Purdue
Alexandra S. Ioanoviciu grad student 2005 Purdue
Martin Conda-Sheridan grad student 2007-2012 Purdue
Asit Kumar Chakraborti post-doc 1987-1989 Purdue
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fan BZ, Hiasa H, Lv W, et al. (2020) Design, synthesis and structure-activity relationships of novel 15-membered macrolides: Quinolone/quinoline-containing sidechains tethered to the C-6 position of azithromycin acylides. European Journal of Medicinal Chemistry. 193: 112222
Wang KB, Elsayed MSA, Wu G, et al. (2019) Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the MYC Promoter G-Quadruplex and Downregulate MYC. Journal of the American Chemical Society
Li XM, Lv W, Guo SY, et al. (2019) Synthesis and structure-bactericidal activity relationships of non-ketolides: 9-Oxime clarithromycin 11,12-cyclic carbonate featured with three-to eight-atom-length spacers at 3-OH. European Journal of Medicinal Chemistry. 171: 235-254
Ma CX, Lv W, Li YX, et al. (2019) Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens. European Journal of Medicinal Chemistry. 169: 1-20
Pommier Y, Cushman M, Doroshow JH. (2018) Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecins. Oncotarget. 9: 37286-37288
Elsayed MSA, Nielsen JJ, Park S, et al. (2018) Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series. Journal of Medicinal Chemistry
Lee HM, Clark EP, Kuijer MB, et al. (2018) Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant gene associated with Angelman syndrome. Molecular Autism. 9: 45
Marzi L, Agama K, Murai J, et al. (2018) Novel fluoroindenoisoquinoline non-camptothecin topoisomerase I inhibitors. Molecular Cancer Therapeutics
Pommier Y, Marzi L, Ohler ZW, et al. (2018) Abstract 4855: Indotecan (LMP400), Imidotecan (LMP776) and LMP744: A new class of non-camptothecin TOP1 inhibitors selective for cancer cells with homologous recombination deficiencies and high SLFN11 expression Cancer Research. 78: 4855-4855
Wang K, Elsayed MSA, Wu G, et al. (2018) Abstract 2662: Indenoisoquinoline topoisomerase I inhibitors target the DNA G-quadruplex formed in the c-Myc promoter and cause MYC downregulation Cancer Research. 78: 2662-2662
See more...